Mizuno N, Niwa T, Yotsumoto Y, Sugiyama Y (September 2003). “Impact of drug transporter studies on drug discovery and development”. Pharmacol. Rev.55 (3): 425–61. doi:10.1124/pr.55.3.1. PMID12869659.
Guengerich FP (June 2001). “Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity”. Chem. Res. Toxicol.14 (6): 611–50. doi:10.1021/tx0002583. PMID11409933.
Schlichting I, Berendzen J, Chu K, Stock AM, Maves SA, Benson DE, Sweet RM, Ringe D, Petsko GA, Sligar SG (March 2000). “The catalytic pathway of cytochrome p450cam at atomic resolution”. Science287 (5458): 1615–22. doi:10.1126/science.287.5458.1615. PMID10698731.
Akagah B, Lormier AT, Fournet A, Figadère B (December 2008). “Oxidation of antiparasitic 2-substituted quinolines using metalloporphyrin catalysts: scale-up of a biomimetic reaction for metabolite production of drug candidates”. Org. Biomol. Chem.6 (24): 4494–7. doi:10.1039/b815963g. PMID19039354.
Boyland E, Chasseaud LF (1969). “The role of glutathione and glutathione S-transferases in mercapturic acid biosynthesis”. Adv. Enzymol. Relat. Areas Mol. Biol.. Advances in Enzymology – and Related Areas of Molecular Biology 32: 173–219. doi:10.1002/9780470122778.ch5. ISBN9780470122778. PMID4892500.
Homolya L, Váradi A, Sarkadi B (2003). “Multidrug resistance-associated proteins: Export pumps for conjugates with glutathione, glucuronate or sulfate”. BioFactors17 (1–4): 103–14. doi:10.1002/biof.5520170111. PMID12897433.
König J, Nies AT, Cui Y, Leier I, Keppler D (December 1999). “Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance”. Biochim. Biophys. Acta1461 (2): 377–94. doi:10.1016/S0005-2736(99)00169-8. PMID10581368.
Rostami-Hodjegan A, Tucker GT (February 2007). “Simulation and prediction of in vivo drug metabolism in human populations from in vitro data”. Nat Rev Drug Discov6 (2): 140–8. doi:10.1038/nrd2173. PMID17268485.
Neuberger A, Smith RL (1983). “Richard Tecwyn Williams: the man, his work, his impact”. Drug Metab. Rev.14 (3): 559–607. doi:10.3109/03602538308991399. PMID6347595.
Estabrook RW (December 2003). “A passion for P450s (remembrances of the early history of research on cytochrome P450)”. Drug Metab. Dispos.31 (12): 1461–73. doi:10.1124/dmd.31.12.1461. PMID14625342.
Mizuno N, Niwa T, Yotsumoto Y, Sugiyama Y (September 2003). “Impact of drug transporter studies on drug discovery and development”. Pharmacol. Rev.55 (3): 425–61. doi:10.1124/pr.55.3.1. PMID12869659.
Guengerich FP (June 2001). “Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity”. Chem. Res. Toxicol.14 (6): 611–50. doi:10.1021/tx0002583. PMID11409933.
Schlichting I, Berendzen J, Chu K, Stock AM, Maves SA, Benson DE, Sweet RM, Ringe D, Petsko GA, Sligar SG (March 2000). “The catalytic pathway of cytochrome p450cam at atomic resolution”. Science287 (5458): 1615–22. doi:10.1126/science.287.5458.1615. PMID10698731.
Akagah B, Lormier AT, Fournet A, Figadère B (December 2008). “Oxidation of antiparasitic 2-substituted quinolines using metalloporphyrin catalysts: scale-up of a biomimetic reaction for metabolite production of drug candidates”. Org. Biomol. Chem.6 (24): 4494–7. doi:10.1039/b815963g. PMID19039354.
Boyland E, Chasseaud LF (1969). “The role of glutathione and glutathione S-transferases in mercapturic acid biosynthesis”. Adv. Enzymol. Relat. Areas Mol. Biol.. Advances in Enzymology – and Related Areas of Molecular Biology 32: 173–219. doi:10.1002/9780470122778.ch5. ISBN9780470122778. PMID4892500.
Homolya L, Váradi A, Sarkadi B (2003). “Multidrug resistance-associated proteins: Export pumps for conjugates with glutathione, glucuronate or sulfate”. BioFactors17 (1–4): 103–14. doi:10.1002/biof.5520170111. PMID12897433.
König J, Nies AT, Cui Y, Leier I, Keppler D (December 1999). “Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance”. Biochim. Biophys. Acta1461 (2): 377–94. doi:10.1016/S0005-2736(99)00169-8. PMID10581368.
Commandeur JN, Stijntjes GJ, Vermeulen NP (June 1995). “Enzymes and transport systems involved in the formation and disposition of glutathione S-conjugates. Role in bioactivation and detoxication mechanisms of xenobiotics”. Pharmacol. Rev.47 (2): 271–330. PMID7568330.
Rostami-Hodjegan A, Tucker GT (February 2007). “Simulation and prediction of in vivo drug metabolism in human populations from in vitro data”. Nat Rev Drug Discov6 (2): 140–8. doi:10.1038/nrd2173. PMID17268485.
Neuberger A, Smith RL (1983). “Richard Tecwyn Williams: the man, his work, his impact”. Drug Metab. Rev.14 (3): 559–607. doi:10.3109/03602538308991399. PMID6347595.
Estabrook RW (December 2003). “A passion for P450s (remembrances of the early history of research on cytochrome P450)”. Drug Metab. Dispos.31 (12): 1461–73. doi:10.1124/dmd.31.12.1461. PMID14625342.
Estabrook RW, Cooper DY, Rosenthal O (1963). “The light reversible carbon monoxide inhibition of steroid C-21 hydroxylase system in adrenal cortex”. Biochem Z338: 741–55. PMID14087340.